Recursion Pharmaceuticals, Inc. (RXRX)
Nasdaq: RXRX · Biological Products, (No Diagnostic Substances) · Salt Lake City, UT · filing with the SEC since 2014
Who owns Recursion Pharmaceuticals, Inc.
As filed with the SECHolders of 5% or more
5
Blackrock, Inc. holds 8.5% of Class A Stock, as its SCHEDULE 13G/A filed Jul 29, 2026 says.
Directors and officers
12
report now, of 20 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 29, 2026 · Class A Stock · 7.2% in Apr 24, 2026
ARK Investment Management LLC
SCHEDULE 13G/A · filed Feb 3, 2026 · Class A Common Stock · 8.47% in Feb 14, 2025
State Street Corporation
SCHEDULE 13G · filed Aug 7, 2026 · COMMON STOCK · 5.5% in May 12, 2026
Vanguard Portfolio Management
SCHEDULE 13G · filed Jul 31, 2026 · Common Stock
Vanguard Capital Management
SCHEDULE 13G · filed Jul 31, 2026 · Common Stock
Baillie Gifford & Co
SCHEDULE 13G/A · filed Feb 5, 2026 · Class A Common Stock · reported falling below 5%, from 6.5% in Feb 12, 2025
RA Capital Management, L.P.
SCHEDULE 13G/A · filed Feb 14, 2025 · Class A Common Stock, par value $0.00001 per share · reported falling below 5%
MDC Capital Partners (Ventures) GP, LP
SCHEDULE 13D/A · filed Dec 23, 2025 · Class A Common Stock, $0.00001 par value per share · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
What RXRX reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Exscientia plc
A company bought · acquisition · Nov 2024 · owns, named in the 10-K filed Feb 25, 2026
18 subsidiaries in 3 countries, from the list filed with the 10-K filed Feb 25, 2026.
Insider tradesForm 4
35sales
0purchases
35sales on a scheduled plan
6people selling
$7.6Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 4, 2025 to Nov 4, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 4, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window6 of 38 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Borgeson Blake | director | 12 | $4.5M | 12 | 0 | $0 |
| Gibson Christopher | Chief Executive Officer | 14 | $2.2M | 14 | 0 | $0 |
| Khan Najat | CEO and President | 4 | $800,000 | 4 | 0 | $0 |
| Taylor Ben R | Chief Financial Officer | 3 | $200,000 | 3 | 0 | $0 |
| Hershberg Robert | director | 1 | $100,000 | 1 | 0 | $0 |
| Bumpus Namandje | director | 2 | $0 | 2 | 0 | $0 |